PER 1.88% 7.9¢ percheron therapeutics limited

Wilsons Report 13 September

  1. 69 Posts.
    lightbulb Created with Sketch. 51
    New report from Wilsons...
    Click HERE for the report
    Valuation. Changes to trial timelines affects our real options NPVs, which reduces our risked valuation to $0.36/share, with 79% of our valuation associated with EU ATL1102 opportunity with the balance in the US market. Our revised un-risked valuation is $1.00/share.
    Last edited by Atomboi: edit link 13/09/22
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢
Change
-0.002(1.88%)
Mkt cap ! $70.77M
Open High Low Value Volume
8.0¢ 8.2¢ 7.8¢ $66.20K 831.8K

Buyers (Bids)

No. Vol. Price($)
3 216590 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 24573 1
View Market Depth
Last trade - 15.45pm 17/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.